Table of Content

1 Gastric Inhibitory Polypeptide Receptor Market Overview
1.1 Gastric Inhibitory Polypeptide Receptor Product Scope
1.2 Gastric Inhibitory Polypeptide Receptor Segment by Type
1.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales by Type (2016 & 2021 & 2027)
1.2.2 HM-15211
1.2.3 LBT-6030
1.2.4 LY-3298176
1.2.5 NNC-92041706
1.2.6 Others
1.3 Gastric Inhibitory Polypeptide Receptor Segment by Application
1.3.1 Global Gastric Inhibitory Polypeptide Receptor Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Metabolic Disorder
1.3.3 Type 2 Diabetes
1.3.4 Obesity
1.3.5 Others
1.4 Gastric Inhibitory Polypeptide Receptor Market Estimates and Forecasts (2016-2027)
1.4.1 Global Gastric Inhibitory Polypeptide Receptor Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Gastric Inhibitory Polypeptide Receptor Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Gastric Inhibitory Polypeptide Receptor Price Trends (2016-2027)

2 Gastric Inhibitory Polypeptide Receptor Estimates and Forecasts by Region
2.1 Global Gastric Inhibitory Polypeptide Receptor Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Gastric Inhibitory Polypeptide Receptor Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2016-2021)
2.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region (2016-2021)
2.3 Global Gastric Inhibitory Polypeptide Receptor Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Gastric Inhibitory Polypeptide Receptor Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Gastric Inhibitory Polypeptide Receptor Estimates and Projections (2016-2027)
2.4.2 Europe Gastric Inhibitory Polypeptide Receptor Estimates and Projections (2016-2027)
2.4.3 China Gastric Inhibitory Polypeptide Receptor Estimates and Projections (2016-2027)
2.4.4 Japan Gastric Inhibitory Polypeptide Receptor Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Gastric Inhibitory Polypeptide Receptor Estimates and Projections (2016-2027)
2.4.6 India Gastric Inhibitory Polypeptide Receptor Estimates and Projections (2016-2027)

3 Global Gastric Inhibitory Polypeptide Receptor Competition Landscape by Players
3.1 Global Top Gastric Inhibitory Polypeptide Receptor Players by Sales (2016-2021)
3.2 Global Top Gastric Inhibitory Polypeptide Receptor Players by Revenue (2016-2021)
3.3 Global Gastric Inhibitory Polypeptide Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastric Inhibitory Polypeptide Receptor as of 2020)
3.4 Global Gastric Inhibitory Polypeptide Receptor Average Price by Company (2016-2021)
3.5 Manufacturers Gastric Inhibitory Polypeptide Receptor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gastric Inhibitory Polypeptide Receptor Market Size by Type
4.1 Global Gastric Inhibitory Polypeptide Receptor Historic Market Review by Type (2016-2021)
4.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
4.1.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Type (2016-2021)
4.1.3 Global Gastric Inhibitory Polypeptide Receptor Price by Type (2016-2021)
4.2 Global Gastric Inhibitory Polypeptide Receptor Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales Forecast by Type (2022-2027)
4.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Type (2022-2027)
4.2.3 Global Gastric Inhibitory Polypeptide Receptor Price Forecast by Type (2022-2027)

5 Global Gastric Inhibitory Polypeptide Receptor Market Size by Application
5.1 Global Gastric Inhibitory Polypeptide Receptor Historic Market Review by Application (2016-2021)
5.1.1 Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
5.1.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Application (2016-2021)
5.1.3 Global Gastric Inhibitory Polypeptide Receptor Price by Application (2016-2021)
5.2 Global Gastric Inhibitory Polypeptide Receptor Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Gastric Inhibitory Polypeptide Receptor Sales Forecast by Application (2022-2027)
5.2.2 Global Gastric Inhibitory Polypeptide Receptor Revenue Forecast by Application (2022-2027)
5.2.3 Global Gastric Inhibitory Polypeptide Receptor Price Forecast by Application (2022-2027)

6 North America Gastric Inhibitory Polypeptide Receptor Market Facts & Figures
6.1 North America Gastric Inhibitory Polypeptide Receptor Sales by Company
6.1.1 North America Gastric Inhibitory Polypeptide Receptor Sales by Company (2016-2021)
6.1.2 North America Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021)
6.2 North America Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type
6.2.1 North America Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2016-2021)
6.2.2 North America Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2022-2027)
6.3 North America Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application
6.3.1 North America Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application (2016-2021)
6.3.2 North America Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application (2022-2027)

7 Europe Gastric Inhibitory Polypeptide Receptor Market Facts & Figures
7.1 Europe Gastric Inhibitory Polypeptide Receptor Sales by Company
7.1.1 Europe Gastric Inhibitory Polypeptide Receptor Sales by Company (2016-2021)
7.1.2 Europe Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021)
7.2 Europe Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type
7.2.1 Europe Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2016-2021)
7.2.2 Europe Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2022-2027)
7.3 Europe Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application
7.3.1 Europe 123 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 123 Sales Breakdown by Application (2022-2027)

8 China Gastric Inhibitory Polypeptide Receptor Market Facts & Figures
8.1 China Gastric Inhibitory Polypeptide Receptor Sales by Company
8.1.1 China Gastric Inhibitory Polypeptide Receptor Sales by Company (2016-2021)
8.1.2 China Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021)
8.2 China Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type
8.2.1 China Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2016-2021)
8.2.2 China Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2022-2027)
8.3 China Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application
8.3.1 China 143 Sales Breakdown by Application (2016-2021)
8.3.2 China 143 Sales Breakdown by Application (2022-2027)

9 Japan Gastric Inhibitory Polypeptide Receptor Market Facts & Figures
9.1 Japan Gastric Inhibitory Polypeptide Receptor Sales by Company
9.1.1 Japan Gastric Inhibitory Polypeptide Receptor Sales by Company (2016-2021)
9.1.2 Japan Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021)
9.2 Japan Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type
9.2.1 Japan Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2016-2021)
9.2.2 Japan Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2022-2027)
9.3 Japan Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gastric Inhibitory Polypeptide Receptor Market Facts & Figures
10.1 Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales by Company
10.1.1 Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales by Company (2016-2021)
10.1.2 Southeast Asia Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021)
10.2 Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type
10.2.1 Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Gastric Inhibitory Polypeptide Receptor Market Facts & Figures
11.1 India Gastric Inhibitory Polypeptide Receptor Sales by Company
11.1.1 India Gastric Inhibitory Polypeptide Receptor Sales by Company (2016-2021)
11.1.2 India Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021)
11.2 India Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type
11.2.1 India Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2016-2021)
11.2.2 India Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Type (2022-2027)
11.3 India Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application
11.3.1 India Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application (2016-2021)
11.3.2 India Gastric Inhibitory Polypeptide Receptor Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gastric Inhibitory Polypeptide Receptor Business
12.1 Alchemia Limited
12.1.1 Alchemia Limited Corporation Information
12.1.2 Alchemia Limited Business Overview
12.1.3 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Alchemia Limited Gastric Inhibitory Polypeptide Receptor Products Offered
12.1.5 Alchemia Limited Recent Development
12.2 AstraZeneca Plc
12.2.1 AstraZeneca Plc Corporation Information
12.2.2 AstraZeneca Plc Business Overview
12.2.3 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Products Offered
12.2.5 AstraZeneca Plc Recent Development
12.3 Carmot Therapeutics, Inc.
12.3.1 Carmot Therapeutics, Inc. Corporation Information
12.3.2 Carmot Therapeutics, Inc. Business Overview
12.3.3 Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Products Offered
12.3.5 Carmot Therapeutics, Inc. Recent Development
12.4 Diabetica Limited
12.4.1 Diabetica Limited Corporation Information
12.4.2 Diabetica Limited Business Overview
12.4.3 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Diabetica Limited Gastric Inhibitory Polypeptide Receptor Products Offered
12.4.5 Diabetica Limited Recent Development
12.5 Longevity Biotech, Inc
12.5.1 Longevity Biotech, Inc Corporation Information
12.5.2 Longevity Biotech, Inc Business Overview
12.5.3 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Products Offered
12.5.5 Longevity Biotech, Inc Recent Development
12.6 Novo Nordisk A/S
12.6.1 Novo Nordisk A/S Corporation Information
12.6.2 Novo Nordisk A/S Business Overview
12.6.3 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Products Offered
12.6.5 Novo Nordisk A/S Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Gastric Inhibitory Polypeptide Receptor Products Offered
12.7.5 Sanofi Recent Development
12.8 Zealand Pharma A/S
12.8.1 Zealand Pharma A/S Corporation Information
12.8.2 Zealand Pharma A/S Business Overview
12.8.3 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Products Offered
12.8.5 Zealand Pharma A/S Recent Development

13 Gastric Inhibitory Polypeptide Receptor Manufacturing Cost Analysis
13.1 Gastric Inhibitory Polypeptide Receptor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gastric Inhibitory Polypeptide Receptor
13.4 Gastric Inhibitory Polypeptide Receptor Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gastric Inhibitory Polypeptide Receptor Distributors List
14.3 Gastric Inhibitory Polypeptide Receptor Customers

15 Market Dynamics
15.1 Gastric Inhibitory Polypeptide Receptor Market Trends
15.2 Gastric Inhibitory Polypeptide Receptor Drivers
15.3 Gastric Inhibitory Polypeptide Receptor Market Challenges
15.4 Gastric Inhibitory Polypeptide Receptor Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gastric Inhibitory Polypeptide Receptor Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Gastric Inhibitory Polypeptide Receptor Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Gastric Inhibitory Polypeptide Receptor Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Region (2016-2021)
Table 5. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Region (2016-2021)
Table 6. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Region (2016-2021)
Table 8. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Gastric Inhibitory Polypeptide Receptor Revenue Share Forecast by Region (2022-2027)
Table 12. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Company (2016-2021)
Table 14. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Company (2016-2021)
Table 16. Global Gastric Inhibitory Polypeptide Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Inhibitory Polypeptide Receptor as of 2020)
Table 17. Global Gastric Inhibitory Polypeptide Receptor Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Gastric Inhibitory Polypeptide Receptor Manufacturing Sites and Area Served
Table 19. Manufacturers Gastric Inhibitory Polypeptide Receptor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Type (2016-2021)
Table 22. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Type (2016-2021)
Table 23. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Type (2022-2027)
Table 26. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Type (2022-2027)
Table 28. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Application (2016-2021)
Table 30. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Application (2016-2021)
Table 31. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Application (2022-2027)
Table 34. Global Gastric Inhibitory Polypeptide Receptor Sales Share by Application (2022-2027)
Table 35. Global Gastric Inhibitory Polypeptide Receptor Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Application (2022-2027)
Table 37. Global Gastric Inhibitory Polypeptide Receptor Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Company (2016-2021)
Table 39. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Company (2016-2021)
Table 40. North America Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Company (2016-2021)
Table 42. North America Gastric Inhibitory Polypeptide Receptor Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
Table 44. North America Gastric Inhibitory Polypeptide Receptor Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2022-2027)
Table 46. North America Gastric Inhibitory Polypeptide Receptor Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
Table 48. North America Gastric Inhibitory Polypeptide Receptor Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2022-2027)
Table 50. Europe Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Company (2016-2021)
Table 52. Europe Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Company (2016-2021)
Table 54. Europe Gastric Inhibitory Polypeptide Receptor Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
Table 56. Europe Gastric Inhibitory Polypeptide Receptor Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2022-2027)
Table 58. Europe Gastric Inhibitory Polypeptide Receptor Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
Table 60. Europe Gastric Inhibitory Polypeptide Receptor Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2022-2027)
Table 62. China Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Company (2016-2021)
Table 63. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Company (2016-2021)
Table 64. China Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Company (2016-2021)
Table 66. China Gastric Inhibitory Polypeptide Receptor Sales by Type (2016-2021) & (K Pcs)
Table 67. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
Table 68. China Gastric Inhibitory Polypeptide Receptor Sales by Type (2022-2027) & (K Pcs)
Table 69. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2022-2027)
Table 70. China Gastric Inhibitory Polypeptide Receptor Sales by Application (2016-2021) & (K Pcs)
Table 71. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
Table 72. China Gastric Inhibitory Polypeptide Receptor Sales by Application (2022-2027) & (K Pcs)
Table 73. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2022-2027)
Table 74. Japan Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Company (2016-2021)
Table 76. Japan Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Company (2016-2021)
Table 78. Japan Gastric Inhibitory Polypeptide Receptor Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
Table 80. Japan Gastric Inhibitory Polypeptide Receptor Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2022-2027)
Table 82. Japan Gastric Inhibitory Polypeptide Receptor Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
Table 84. Japan Gastric Inhibitory Polypeptide Receptor Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2022-2027)
Table 98. India Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) by Company (2016-2021)
Table 99. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Company (2016-2021)
Table 100. India Gastric Inhibitory Polypeptide Receptor Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Company (2016-2021)
Table 102. India Gastric Inhibitory Polypeptide Receptor Sales by Type (2016-2021) & (K Pcs)
Table 103. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2016-2021)
Table 104. India Gastric Inhibitory Polypeptide Receptor Sales by Type (2022-2027) & (K Pcs)
Table 105. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type (2022-2027)
Table 106. India Gastric Inhibitory Polypeptide Receptor Sales by Application (2016-2021) & (K Pcs)
Table 107. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2016-2021)
Table 108. India Gastric Inhibitory Polypeptide Receptor Sales by Application (2022-2027) & (K Pcs)
Table 109. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application (2022-2027)
Table 110. Alchemia Limited Corporation Information
Table 111. Alchemia Limited Description and Business Overview
Table 112. Alchemia Limited Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Alchemia Limited Gastric Inhibitory Polypeptide Receptor Product
Table 114. Alchemia Limited Recent Development
Table 115. AstraZeneca Plc Corporation Information
Table 116. AstraZeneca Plc Description and Business Overview
Table 117. AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. AstraZeneca Plc Gastric Inhibitory Polypeptide Receptor Product
Table 119. AstraZeneca Plc Recent Development
Table 120. Carmot Therapeutics, Inc. Corporation Information
Table 121. Carmot Therapeutics, Inc. Description and Business Overview
Table 122. Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Carmot Therapeutics, Inc. Gastric Inhibitory Polypeptide Receptor Product
Table 124. Carmot Therapeutics, Inc. Recent Development
Table 125. Diabetica Limited Corporation Information
Table 126. Diabetica Limited Description and Business Overview
Table 127. Diabetica Limited Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Diabetica Limited Gastric Inhibitory Polypeptide Receptor Product
Table 129. Diabetica Limited Recent Development
Table 130. Longevity Biotech, Inc Corporation Information
Table 131. Longevity Biotech, Inc Description and Business Overview
Table 132. Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Longevity Biotech, Inc Gastric Inhibitory Polypeptide Receptor Product
Table 134. Longevity Biotech, Inc Recent Development
Table 135. Novo Nordisk A/S Corporation Information
Table 136. Novo Nordisk A/S Description and Business Overview
Table 137. Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Novo Nordisk A/S Gastric Inhibitory Polypeptide Receptor Product
Table 139. Novo Nordisk A/S Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Sanofi Gastric Inhibitory Polypeptide Receptor Product
Table 144. Sanofi Recent Development
Table 145. Zealand Pharma A/S Corporation Information
Table 146. Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Zealand Pharma A/S Description and Business Overview
Table 148. Zealand Pharma A/S Gastric Inhibitory Polypeptide Receptor Product
Table 149. Zealand Pharma A/S Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Gastric Inhibitory Polypeptide Receptor Distributors List
Table 153. Gastric Inhibitory Polypeptide Receptor Customers List
Table 154. Gastric Inhibitory Polypeptide Receptor Market Trends
Table 155. Gastric Inhibitory Polypeptide Receptor Market Drivers
Table 156. Gastric Inhibitory Polypeptide Receptor Market Challenges
Table 157. Gastric Inhibitory Polypeptide Receptor Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastric Inhibitory Polypeptide Receptor Product Picture
Figure 2. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2021 & 2027
Figure 3. HM-15211 Product Picture
Figure 4. LBT-6030 Product Picture
Figure 5. LY-3298176 Product Picture
Figure 6. NNC-92041706 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2021 & 2027
Figure 9. Metabolic Disorder Examples
Figure 10. Type 2 Diabetes Examples
Figure 11. Obesity Examples
Figure 12. Others Examples
Figure 13. Global Gastric Inhibitory Polypeptide Receptor Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Gastric Inhibitory Polypeptide Receptor Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Gastric Inhibitory Polypeptide Receptor Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Gastric Inhibitory Polypeptide Receptor Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Gastric Inhibitory Polypeptide Receptor Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Gastric Inhibitory Polypeptide Receptor Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Gastric Inhibitory Polypeptide Receptor Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Gastric Inhibitory Polypeptide Receptor Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Gastric Inhibitory Polypeptide Receptor Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Gastric Inhibitory Polypeptide Receptor Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Gastric Inhibitory Polypeptide Receptor Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Gastric Inhibitory Polypeptide Receptor Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Gastric Inhibitory Polypeptide Receptor Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Gastric Inhibitory Polypeptide Receptor Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Gastric Inhibitory Polypeptide Receptor Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Gastric Inhibitory Polypeptide Receptor Players Market Share by Revenue in Gastric Inhibitory Polypeptide Receptor: 2016 & 2020
Figure 32. Gastric Inhibitory Polypeptide Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Type (2016-2021)
Figure 34. Global Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Gastric Inhibitory Polypeptide Receptor Revenue Share by Application (2016-2021)
Figure 36. Global Gastric Inhibitory Polypeptide Receptor Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020
Figure 38. North America Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020
Figure 39. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020
Figure 40. Europe Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020
Figure 41. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020
Figure 42. China Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020
Figure 43. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020
Figure 44. Japan Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020
Figure 45. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020
Figure 46. Southeast Asia Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020
Figure 47. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Type in 2020
Figure 48. India Gastric Inhibitory Polypeptide Receptor Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Gastric Inhibitory Polypeptide Receptor
Figure 51. Manufacturing Process Analysis of Gastric Inhibitory Polypeptide Receptor
Figure 52. Gastric Inhibitory Polypeptide Receptor Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed